Role of the COMT gene Val158Met polymorphism in mental disorders: A review

European Psychiatry

Volumn 22, Issue 5, 2007, Pages 276-281

  Hosák, Ladislav ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

COMT gene; Mental disorders; Pleiotropic effect; Val158Met polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ANOREXIA NERVOSA; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT SURVEY;

CATECHOL O-METHYLTRANSFERASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENTAL DISORDERS; METHIONINE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SOCIAL ENVIRONMENT; VALINE;

EID: 34447636936     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.02.002     Document Type: Short Survey

References (59)

1. Alsobrook II J.P., Zohar A.H., Leboyer M., Chabane N., Ebstein R., and Pauls D.L. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet (Neuropsychiatr Genet) 114 (2002) 116-120
2. Bilder R.M., Volavka J., Lachman H.M., and Grace A.A. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29 (2004) 1943-1961
3. Chen C.H., Lee Y.R., Chung M.Y., Wei F.C., Koong F.J., Shaw C.K., et al. Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia. Am J Psychiatry 156 (1999) 1273-1275
4. Daniels J.K., Williams N.M., Williams J., Jones L.A., Cardno A.G., Murphy K.C., et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 153 (1996) 268-270
5. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98 (2001) 6917-6922
6. Eisenberg J., Mei-Tal G., Steinberg A., Tartakovsky E., Zohar A., Gritsenko I., et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet (Neuropsychiatr Genet) 88 (1999) 497-502
7. Erdal M.E., Tot S., Yazici K., Yazici A., Herken H., Erdem P., et al. Lack of association of catechol-o-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depres Anxiety 18 (2003) 41-45
8. Fan J.B., Zhang C.S., Gu N.F., Li X.W., Sun W.W., Wang H.Y., et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 57 (2005) 139-144
9. Frisch A., Laufer N., Danziger Y., Michaelovsky E., Leor S., Carel C., et al. Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients. Mol Psychiatry 6 (2001) 243-245
10. Gabrovsek M., Brecelj-Anderluh M., Bellodi L., Cellini E., Di Bella D., Estivill X., et al. Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. Am J Med Genet (Neuropsychiatr Genet) 124B (2004) 68-72
11. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., et al. Executive subprocesses in working memory. Arch Gen Psychiatry 60 (2003) 889-896
12. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160 (2003) 636-645
13. Gutiérrez B., Bertranpetit J., Guillamat R., Valles V., Arranz M.J., Kerwin R., et al. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry 154 (1997) 113-115
14. Hallikainen T., Lachman H., Saito T., Volavka J., Kauhanen J., Salonen J.T., et al. Lack of association between the functional variant of the catechol-O-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior. Am J Med Genet (Neuropsychiatr Genet) 96 (2000) 348-352
15. Handoko H.Y., Nyholt D.R., Hayward N.K., Nertney D.A., Hannah D.E., Windus L.C., et al. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry (2004) 10.1038/sj.mp 4001606 advance online publication 26 October 2004
16. Hawi Z., Millar N., Daly G., Fitzgerald M., and Gill M. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet (Neuropsychiatr Genet) 96 (2000) 282-284
17. Horowitz R., Kotler M., Shufman E., Aharoni S., Kremer I., Cohen H., et al. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet (Neuropsychiatr Genet) 96 (2000) 599-603
18. http://www4.infotrieve.com/newmedline/search.asp
19. Inada T., Nakamura A., and Iijima Y. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 120 (2003) 35-39
20. Joober R., Gauthier J., Lal S., Bloom D., Lalonde P., Rouleau G., et al. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin card sorting test. Arch Gen Psychiatry 59 (2002) 662-663
21. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18 (1993) 75-113
22. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94 (1997) 4572-4575
23. Karayiorgou M., Gogos J.A., Galke B.L., Wolyniec P.S., Nestadt G., Antonarakis S.E., et al. Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biol Psychiatry 43 (1998) 425-431
24. Karoum F., Chrapusta S.J., and Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex. J Neurochem 63 (1994) 972-979
25. Kendler K.S. "A gene for...": the nature of gene action in psychiatric disorders. Am J Psychiatry 162 (2005) 1243-1252
26. Kirov G., Murphy K.C., Arranz M.J., Jones I., McCandles F., Kunugi H., et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry 3 (1998) 342-345
27. Kotler M., Barak P., Cohen H., Averbuch I.E., Grinshpoon A., Gritsenko I., et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet (Neuropsychiatr Genet) 88 (1999) 628-633
28. Kunugi H., Vallada H.P., Hoda F., Kirov G., Gill M., Aitchison K.J., et al. No evidence for an association of affective disorders with high- or low-activity allele of catechol-O-methyltransferase gene. Biol Psychiatry 42 (1997) 282-285
29. Kunugi H., Vallada H.P., Sham P.C., Hoda F., Arranz M.J., Li T., et al. Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet 7 (1997) 97-101
30. Lachman H.M., Morrow B., Shprintzen R., Veit S., Parsia S.S., Faedda G., et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet (Neuropsychiatr Genet) 67 (1996) 468-472
31. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
32. Li T., Chen C.K., Hu X., Ball D., Lin S.K., Chen W., et al. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet (Neuropsychiatr Genet) 129B (2004) 120-124
33. Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., et al. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet 6 (1996) 131-133
34. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., and Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159 (2002) 652-654
35. Meira-Lima I., Shavitt R.G., Miguita K., Ikenaga E., Miguel E.C., and Vallada H. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Gen Brain Behav 3 (2004) 75-79
36. Nutt J.G. Catechol-O-methyltransferase inhibition and the treatment of Parkinson's disease. Adv Pharmacol 42 (1998) 331-334
37. Ohmori O., Shinkai T., Kojima H., Terao T., Suzuki T., Mita T., et al. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 243 (1998) 109-112
38. Palmatier M.A., Kang A.M., and Kidd K.K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46 (1999) 557-567
39. Papolos D.F., Veit S., Faedda G.L., Saito T., and Lachman H.M. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 3 (1998) 346-349
40. Payton A., Holmes J., Barrett J.H., Hever T., Fitzpatrick H., Trumper A.L., et al. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet (Neuropsychiatr Genet) 105 (2001) 464-470
41. Pritchard J.K., and Rosenberg N.A. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65 (1999) 220-228
42. Qian Q., Wang Y., Zhou R., Li J., Wang B., Glatt S., et al. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet (Neuropsychiatr Genet) 118B (2003) 103-109
43. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martínez-Larrea A., et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161 (2004) 1110-1112
44. Sazci A., Ergul E., Kucukali I., Kilic G., Kaya G., and Kara I. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Mol Brain Res 132 (2004) 51-56
45. Schrag A. Entacapone in the treatment of Parkinson's disease. Lancet Neurol 4 (2005) 366-370
46. Shifman S., Bronstein M., Sternfeld M., Pisanté A., Weizman A., Reznik I., et al. COMT: A common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 128B (2004) 61-64
47. Shifman S., Bronstein M., Sternfeld M., Pisanté-Shalom A., Lev-Lehman E., Weizman A., et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71 (2002) 1296-1302
48. Spielman R.S., McGinnis R.E., and Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52 (1993) 506-516
49. Strous R.D., Bark N., Parsia S.S., Volavka J., and Lachman H.M. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69 (1997) 71-77
50. Strous R.D., Bark N., Woerner M., and Lachman H.M. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41 (1997) 493-495
51. Strous R.D., Nolan K.A., Lapidus R., Diaz L., Saito T., and Lachman H.M. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet (Neuropsychiatr Genet) 120B (2003) 29-34
52. Tiihonen J., Hallikainen T., Lachman H., Saito T., Volavka J., Kauhanen J., et al. Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 4 (1999) 286-289
53. Turic D., Williams H., Langley K., Owen M., Thapar A., and O'Donovan M.C. A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD). Am J Med Genet (Neuropsychiatr Genet) 133B (2005) 64-67
54. Vandenbergh D.J., Rodriguez L.A., Miller I.T., Uhl G.R., and Lachman H.M. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet (Neuropsychiatr Genet) 74 (1997) 439-442
55. Volavka J., Kennedy J.L., Ni X., Czobor P., Nolan K., Sheitman B., et al. COMT158 polymorphism and hostility. Am J Med Genet (Neuropsychiatr Genet) 127B (2004) 28-29
56. Wei J., and Hemmings G.P. Lack of evidence for association between the COMT locus and schizophrenia. Psychiatr Genet 9 (1999) 183-186
57. 108/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 120B (2003) 47-50
58. Xie T., Ho S.L., and Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56 (1999) 31-38
59. Yirmiya N., Pilowsky T., Nemanov L., Arbelle S., Feinsilver T., Fried I., et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet (Neuropsychiatr Genet) 105 (2001) 381-386